The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients
Authors:
- M. Djalali JalaliMJM. Djalali Jalali
- A. Djazayery JazayeryAJA. Djazayery Jazayery
- A. SaedisomeoliaASA. Saedisomeolia
- M. Reza EshraghianMEM. Reza Eshraghian
- F. ToorangFTF. Toorang
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 20 (5) , 326-331
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Evaluating cardiovascular mortality in type 2 diabetes patients: an analysis based on competing risks Markov Chains and additive regression modelsJournal of Evaluation in Clinical Practice, 2007
- n-3 Fatty Acids in the Treatment of Diabetic PatientsDiabetes Care, 2007
- Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic reviewAtherosclerosis, 2006
- The Epidemiology of Low-Grade Chronic Systemic Inflammation and Type 2 DiabetesDiabetes Technology & Therapeutics, 2006
- Consumption of (n-3) Fatty Acids Is Related to Plasma Biomarkers of Inflammation and Endothelial Activation in WomenThe Journal of Nutrition, 2004
- C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery diseaseThe American Journal of Cardiology, 2001
- Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine StudyThe American Journal of Clinical Nutrition, 2001
- A Polyunsaturated Fatty Acid Diet Lowers Blood Pressure and Improves Antioxidant Status in Spontaneously Hypertensive RatsThe Journal of Nutrition, 2001
- Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acidsThe American Journal of Clinical Nutrition, 2000
- The importance of lipid-derived malondialdehyde in diabetes mellitusDiabetologia, 2000